November 2016: Promotion of iCal D3 by Stirling Anglian
Published 22 December 2016
© Crown copyright 2016
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/advertising-investigations-november-2016/november-2016-promotion-of-ical-d3-by-stirling-anglian
MHRA received a complaint from Consilient Health concerning the provision of free samples of a medicine by Stirling Anglian representatives at the Scottish Prescribing Advisers Association Annual Conference held on 24th October in Glasgow. The complainant was concerned that free samples of iCal D3 chewable tablets were handed out to healthcare professionals to allow them to taste the medicine.
MHRA upheld the complaint. Stirling Anglian agreed to take action to ensure that samples of a medicine are not provided to healthcare professionals unless the requirements of regulation 298 are met.